ProQR Therapeutics (PRQR) Net Margin Growth (1y) (2013 - 2026)
ProQR Therapeutics (PRQR) Net Margin Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -185.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -763.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 447.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 673.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,097.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -392.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2,208.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 29,636.00 |
| 10 | ProQR Therapeutics | 206.80 Mn | 111.86 Mn | - | -43,525.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43,525.00 |
| Dec 31, 2025 | 4,638.00 |
| Sep 30, 2025 | -16,189.00 |
| Jun 30, 2025 | -29,424.00 |
| Mar 31, 2025 | -5,095.00 |
| Dec 31, 2024 | -6,339.00 |
| Sep 30, 2024 | 22,045.00 |
| Jun 30, 2024 | 62,062.00 |
| Mar 31, 2024 | 122,516.00 |
| Dec 31, 2023 | 169,650.00 |
| Sep 30, 2023 | 242,338.00 |
| Jun 30, 2023 | 80,980.00 |
| Mar 31, 2023 | -14,867.00 |
| Dec 31, 2022 | 577,704.00 |
| Sep 30, 2022 | -113,905.00 |
| Jun 30, 2022 | 506,474.00 |
| Mar 31, 2022 | -114,442.00 |
| Dec 31, 2021 | -750,880.00 |
| Sep 30, 2021 | -160,188.00 |
| Jun 30, 2021 | -641,142.00 |